FiercePharma

In strategic pivot under new CEO Richard Francis, Teva plots cuts to its generics portfolio

Even as drug shortages squeeze the pharmaceutical industry and weigh on patients, one of the world’s top generic manufacturers is planning to cut parts of its portfolio. At Teva’s recent investor day, ...
Business Wire

Research and Markets: Countering Generic and Biosimilar Threats - Generics Currently Account for More Than 10% of All Drug Sales

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/89beda/countering_generic) has announced the addition of Cutting Edge ...
Business Wire

Research and Markets: Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/07fbd3/generic_growth_str) has announced the addition of the "Generic Growth ...